• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Financial Services·PRISMMEDI.BO
Share

Prism Medico and Pharmacy Limited Stocks

₹ 32.5Last Updated 19.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

₹ 2.17M

₹ 32.5
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Prism Medico & Pharmacy Ltd., an entity in its developmental stages, is primarily involved in the acquisition, distribution, and sale of agricultural goods. Its current portfolio includes cattle feed, various fertilizers (encompassing organic and bio-fertilizers), bio-organics, bio-pesticides, seeds, and other related farm products. The company has articulated a broad future vision, intending to engage in manufacturing, trading, wholesaling, retailing, distributing, and operating as agents, repackers, analytical chemists, druggists, refiners, processors, merchants, and stockists. This expansive scope covers a wide array of products, such as chemicals, serums, antibiotics, medicines, drugs, pharmaceuticals, pesticides, dyes, soaps, oils, perfumes, cosmetics, and proprietary medications. Established on February 21, 1985, the firm's headquarters are situated in Mohali, India.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 08:00

JPMorgan has issued its first long-term forecast for Bitcoin. It could outperform stocks and gold

21.10.2026 07:00

Boeing has secured approval for the largest aircraft in the 737 Max family. Why is this important?

21.10.2026 04:37

AI stocks surged: one of the largest server suppliers eased market concerns

21.10.2026 03:02

SpaceX and Tesla Are Discussing a Merger — Musk

21.10.2026 01:11

SpaceX's profit more than doubled expectations. The annual revenue target is $1 trillion.

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026